BioSig Technologies, Inc. (BSGM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BioSig Technologies, Inc. on March 9, 2021. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report serves as a Regulation FD disclosure regarding an upcoming corporate event.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a specific event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a scheduled presentation at an investor conference.
Guidance, Outlook, and Management Commentary
Management announced that the Company will present at the 33rd Annual Virtual ROTH Conference, scheduled for March 15-17, 2021. The filing explicitly states that the Company undertakes no obligation to update, supplement, or amend the materials attached as Exhibit 99.1. No specific financial guidance or forward-looking projections are included in the text of this report.
Key Facts for Investor Verification
- Verify the date and time of the presentation at the 33rd Annual Virtual ROTH Conference (March 15-17, 2021).
- Review the attached Press Release (Exhibit 99.1) for specific details regarding the presentation content.
- Note that the information in this Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings.
- Confirm that no financial data or updated guidance is contained within this specific 8-K filing.